Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-06-02

FDA Approved: NADOLOL — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

The FDA approved Amneal's original application for a generic nadolol, a non-selective beta-blocker used to treat hypertension and to prevent esophageal variceal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nadolol (Nadolol)

Snippet

ORIG AP for NADOLOL (NADOLOL)